MedPath

Research on Ringworm in Unani Medicine

Phase 2
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2023/06/053844
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Clinically diagnosed cases of Tinea Corporis with less than or equal to 3% body surface area (calculated by the palm rule)Patients whose KOH is positive.

2. Patient of either gender.

3. Age group 18-60 years.

4).Patient with controlled diabetes

Exclusion Criteria

1.Known cases of tinea corporis on medication one month prior

2. Patients of T. Corporis with more than 3% body surface area.

3. Patients whose KOH is negative.

4. Patients below and above the age of 18 and 60 years respectively.

5. Patients suffering from concomitant skin diseases like psoriasis & Eczema and other types of tinea like T. Cruris, T. Facei, T.Capitis, T.Unguum, T.Manuum.

6. Pregnant & Lactating Women.

7. Known history of impaired hepatic, renal or cardiovascular functions in patients.

8. Uncontrolled cases of Diabetes and other immunocompromised patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary End Points: <br/ ><br>complete clearance among groups at the end of the intervention <br/ ><br>Secondary End Points: <br/ ><br>a) Comparison of achieved clinical cure among groups at the end of the intervention <br/ ><br>Timepoint: 3 Weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Secondary End Points: <br/ ><br>a) Comparison of achieved clinical cure among groups at the end of the intervention <br/ ><br>b) Comparison of achieved Mycological cure among groups at the end of the <br/ ><br>interventionTimepoint: 3 Weeks
© Copyright 2025. All Rights Reserved by MedPath